Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(15)
T. J. Yang
1
He Kyoung Lim
1
Scott W. Grimm
1
Heidi J. Einolf
1
Konstantine W. Skordos
1
Journals
(1)
DRUG METAB DISPOSITION
1
Keywords
(4)
Embed
Subscribe
Academic
Authors
K.-H. J. Ling
K.-H. J. Ling,Endocrinology,Pharmacology
Edit
K.-H. J. Ling
Publications:
1
|
Citations:
13
Fields:
Endocrinology
,
Pharmacology
View FAQ about top research areas and Fields of study
Collaborated with
15 co-authors
in 2009
|
Cited by
52 authors
Cumulative
Annual
Sort by:
Publications
(1)
BibTeX
|
RIS
|
RefWorks
Download
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
(
Citations: 13
)
S. W. Grimm
,
H. J. Einolf
,
S. D. Hall
,
K. He
,
H.-K. Lim
,
K.-H. J. Ling
,
C. Lu
,
A. A. Nomeir
,
E. Seibert
,
K. W. Skordos
,
G. R. Tonn
,
R. Van Horn
http://academic.research.microsoft.com/io.ashx?type=5&id=38294615&selfId1=39559556&selfId2=0&maxNumber=12&query=
Journal:
Drug Metabolism and Disposition - DRUG METAB DISPOSITION
, vol. 37, no. 7, pp. 1355-1370, 2009
Sort by:
Citations
(13 times by 13 publications)
Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib
Pei-pei Dong
,
Zhong-ze Fang
,
Yan-yan Zhang
,
Guang-bo Ge
,
Yu-xi Mao
,
Liang-liang Zhu
,
Yan-qing Qu
,
Wei Li
,
Li-ming Wang
,
Chang-xiao Liu
,
Ling Yang
Journal:
Acta Pharmacologica Sinica - ACTA PHARMACOL SIN
, vol. 32, no. 3, pp. 399-407, 2011
Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans
J Honkalammi
,
M Niemi
,
P J Neuvonen
,
J T Backman
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 89, no. 4, pp. 579-586, 2011
Drug interactions evaluation: An integrated part of risk assessment of therapeutics
(
Citations: 11
)
Lei Zhang
,
Kellie S. Reynolds
,
Ping Zhao
,
Shiew-Mei Huang
Journal:
Toxicology and Applied Pharmacology - TOXICOL APPL PHARMACOL
, vol. 243, no. 2, pp. 134-145, 2010
In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A
(
Citations: 2
)
Thomas M. Polasek
,
Janani S. Sadagopal
,
David J. Elliot
,
John O. Miners
Journal:
European Journal of Clinical Pharmacology - EUR J CLIN PHARMACOL
, vol. 66, no. 3, pp. 275-283, 2010
System-Dependent Outcomes during the Evaluation of Drug Candidates as Inhibitors of Cytochrome P450 (CYP) and Uridine Diphosphate Glucuronosyltransferase (UGT) Enzymes: Human Hepatocytes versus Liver Microsomes versus Recombinant Enzymes
(
Citations: 2
)
Andrew PARKINSON
,
Faraz KAZMI
,
David B. BUCKLEY
,
Phyllis YERINO
,
Brian W. OGILVIE
,
Brandy L. PARIS
Journal:
Drug Metabolism and Pharmacokinetics - DRUG METAB PHARMACOKINET
, vol. 25, no. 1, pp. 16-27, 2010
Comments